Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kailin Xing"'
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 3, Pp n/a-n/a (2021)
Abstract Background S‐adenosylmethionine decarboxylase proenzyme (AMD1) is a key enzyme involved in the synthesis of spermine (SPM) and spermidine (SPD), which are associated with multifarious cellular processes. It is also found to be an oncogene
Externí odkaz:
https://doaj.org/article/2a852126b86f4398b8b049c3f97ac2e9
Publikováno v:
Current Problems in Cancer. 43:411-420
Thymic carcinomas (TCs) and thymic neuroendocrine tumors (TNETs) are aggressive cancers with poor survival outcome and limited investigation. This study is to investigate clinicopathologic features on TC and TNET patients' prognosis of a large cohort
Publikováno v:
BMC Immunology. 2015, Vol. 16 Issue 1, p1-9. 9p.
Publikováno v:
Oncology Reports.
The discovery of epidermal growth factor receptor (EGFR)‑sensitive mutations in non‑small cell lung cancer (NSCLC) and the successful clinical application of EGFR tyrosine kinase inhibitors (TKIs) have changed the regimen of lung cancer therapy f
Publikováno v:
BMC Immunology
Background Programmed cell death 1 (PD-1) is a key cell-surface receptor of CD28 superfamily that triggers inhibitory pathways to attenuate T-cell responses and promote T-cell tolerance. As a crucial role in tumor immunity, PD-1 has been a focus of s
Autor:
Xiaoyan Zhou, Jialei Wang, Xianghua Wu, Jianhua Chang, Xinmin Zhao, Aiqun Hu, Kailin Xing, Zhiguo Luo, Si Sun, Hui Yu, Huijie Wang
Publikováno v:
Medical oncology (Northwood, London, England). 31(7)
Mutations of epidermal growth factor receptor (EGFR) gene are good predictors of response to treatment with EGFR tyrosine kinase inhibitors (TKIs) for non-small cell lung cancer (NSCLC). It is well established that classic mutations, such as in-frame